Obesity Clinical Trial
Official title:
Study of the Nutraceutical Properties and Health Benefits of Traditional Components of the Mediterranean Diet - A Cross Over Interventional Study
The present protocol is designed to conduct nutrigenomic and nutrigenetic studies on foods conforming to the Mediterranean diet, in order to determine the effect functional foods have on blood parameters (cholesterol metabolism, glucose metabolism, hepatic function, inflammation, nutritional status) and body composition in the context of four different diets (standard, high fat, high protein, low carbohydrate). The study focuses on the effect of these nutraceutical foods in relation to different diets. Diets were chosen to reflect the standard reference diets used by the general population, so as the outcomes of the addition of each interventional food element may be interpreted in the context of a variety of dietary patterns.
This study envisages the enrollment of subjects, to be recruited consecutively from May 2013
to May 2015 from the staff of the laboratory of the Evaluation of Nutritional State,
Nutrigenetics and nutrigenomics of the Human Nutrition and Diet section of the University of
Rome Tor Vergata.
The study will be conducted in accordance with the Declaration of Helsinki, and approved by
the Committee of the Ministero delle Politiche Alimentari e Forestali (MIPAAF) , Italy,
approved by DM 06/12/2011 n° prot. 32064. All participants will be required to provide
written informed consent for the study.
At the time of recruitment, relevant subject data will be collected including clinical
history, dietary habits, pharmacological therapy, smoking habit, alcohol consumption and
level of physical activity.
Exclusion criteria include history of coronary vascular disease, peripheral or cerebro-
vascular disease, hepatic disease, diagnosis of diabetes mellitus, autoimmune disease,
immunodeficiency syndrome or malignant neoplasia.
The subjects enrolled will undergo:
- Anthropometric measures (body weight, height, waist, hip, abdominal, neck, arm and
forearm circumferences).
- Skin fold measurements (bicipital, tricipital, subscapular, pectoral, supra iliac,
abdominal, anterior thigh, internal thigh, supra patellar and popliteal);
- Blood Pressure;
- Body composition evaluation (bone, fat and lean mass), evaluated by DEXA (iDXA; GE
- Medical Systems, Milwaukee, WI) (Dual energy X-ray Absorptiometry; DPX Lunar Radiation
Corp., Madison, Wisconsin, USA);
- Distribution of body fluids, evaluated by bioimpedensometry. Resistance, reactance,
phase angle at 50 kHz will be measured using the Bioelectrical Impedance Analysis
method (BIA 101S, by Akern/RIL System-Florence
- Analysis of genetic expression Participants will be randomized into groups.
Each group will cycle through different interventions, according to a cross over study. The
interventions are represented by different dietary plans based on different meals,
consisting of:
1. Standard Diet (SD) alone, and SD with functional food (40g of hazelnuts or 150 ml of
biological red wine, or 100g of chestnuts, or 200g of wild mixed greens, or 100 g of
olive oil, or 100 g of chocolate);
2. High Fat diet (HF) alone, and HF with functional food (40g of hazelnuts or 150 ml of
biological red wine, or 100g of chestnuts, or 200g of wild mixed greens, or 100 g of
olive oil, or 100 g of chocolate).
3. Low Carbohydrate diet (LC) alone, and LC with functional food (40g of hazelnuts or 150
ml of biological red wine, or 100g of chestnuts, or 200g of wild mixed greens, or 100 g
of olive oil, or 100 g of chocolate).
4. High Protein (HP) alone, and HP with functional food (40g of hazelnuts or 150 ml of
biological red wine, or 100g of chestnuts, or 200g of wild mixed greens, or 100 g of
olive oil, or 100 g of chocolate).
The duration of the experimental period is 4 weeks for each diet, with a wash-out period of
3 weeks at the beginning of the study between one diet and the next.
;
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |